Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1161)
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
5,500
Price
$22.88
Total Value
$125.83K
Shares Held After
55,286
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.22
Total Value
$68.67K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$571.49
Total Value
$809.80K
Shares Held After
40,633
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,653
Price
$570.57
Total Value
$943.16K
Shares Held After
42,050
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,891
Price
$569.75
Total Value
$1.08M
Shares Held After
43,703
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
583
Price
$568.58
Total Value
$331.48K
Shares Held After
45,594
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,023
Price
$567.61
Total Value
$580.67K
Shares Held After
46,177
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,311
Price
$566.56
Total Value
$742.76K
Shares Held After
47,200
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,502
Price
$565.75
Total Value
$849.76K
Shares Held After
48,511
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
649
Price
$571.92
Total Value
$371.18K
Shares Held After
18,876
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,755
Price
$571.10
Total Value
$1.00M
Shares Held After
19,525
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,405
Price
$570.05
Total Value
$1.37M
Shares Held After
21,280
% of Holdings
10.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,107
Price
$569.01
Total Value
$629.90K
Shares Held After
23,685
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
919
Price
$567.81
Total Value
$521.82K
Shares Held After
24,792
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,449
Price
$566.73
Total Value
$821.19K
Shares Held After
25,711
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,716
Price
$565.85
Total Value
$971.00K
Shares Held After
27,160
% of Holdings
5.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
36
Price
$164.07
Total Value
$5.91K
Shares Held After
7,666
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
409
Price
$163.56
Total Value
$66.89K
Shares Held After
7,702
% of Holdings
5.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
231
Price
$162.38
Total Value
$37.51K
Shares Held After
8,111
% of Holdings
2.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
280
Price
$161.62
Total Value
$45.25K
Shares Held After
8,342
% of Holdings
3.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
44
Price
$160.83
Total Value
$7.08K
Shares Held After
8,622
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
5,000
Price
$4.82
Total Value
$24.09K
Shares Held After
261,388
% of Holdings
1.9%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
74
Price
$151.94
Total Value
$11.24K
Shares Held After
21,159
% of Holdings
0.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
35,947
Price
$18.15
Total Value
$652.44K
Shares Held After
1,206,026
% of Holdings
2.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
894
Price
$18.15
Total Value
$16.23K
Shares Held After
9,682
% of Holdings
8.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
90,943
Price
$18.15
Total Value
$1.65M
Shares Held After
5,058,604
% of Holdings
1.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
45,709
Price
$18.15
Total Value
$829.62K
Shares Held After
1,637,302
% of Holdings
2.7%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
165
Price
$67.14
Total Value
$11.08K
Shares Held After
1,107,504
% of Holdings
0.0%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
1,008
Price
$66.46
Total Value
$66.99K
Shares Held After
1,107,669
% of Holdings
0.1%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
1,007
Price
$65.91
Total Value
$66.37K
Shares Held After
1,108,677
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
28,583
Price
$18.48
Total Value
$528.21K
Shares Held After
1,241,973
% of Holdings
2.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
710
Price
$18.48
Total Value
$13.12K
Shares Held After
10,576
% of Holdings
6.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
72,310
Price
$18.48
Total Value
$1.34M
Shares Held After
5,149,547
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
36,345
Price
$18.48
Total Value
$671.66K
Shares Held After
1,683,011
% of Holdings
2.1%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
7,568
Price
$66.13
Total Value
$500.46K
Shares Held After
1,109,684
% of Holdings
0.7%
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
Chacon Quiros Juan Jose — Director
Shares
22,610
Price
$65.66
Total Value
$1.48M
Shares Held After
1,117,252
% of Holdings
2.0%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,000
Price
$3.20
Total Value
$16.00K
Shares Held After
11,375
% of Holdings
30.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$162.53
Total Value
$487.59
Shares Held After
8,666
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
28
Price
$161.22
Total Value
$4.51K
Shares Held After
8,669
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
330
Price
$160.40
Total Value
$52.93K
Shares Held After
8,697
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
375
Price
$159.46
Total Value
$59.80K
Shares Held After
9,027
% of Holdings
4.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
190
Price
$158.65
Total Value
$30.14K
Shares Held After
9,402
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
74
Price
$157.86
Total Value
$11.68K
Shares Held After
9,592
% of Holdings
0.8%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
2,000
Price
$3.20
Total Value
$6.40K
Shares Held After
29,375
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
20
Price
$567.41
Total Value
$11.35K
Shares Held After
40,513
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,950
Price
$566.70
Total Value
$1.11M
Shares Held After
40,533
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,220
Price
$565.36
Total Value
$1.82M
Shares Held After
42,483
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,796
Price
$564.53
Total Value
$1.01M
Shares Held After
45,703
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,316
Price
$563.49
Total Value
$741.56K
Shares Held After
47,499
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
878
Price
$562.37
Total Value
$493.76K
Shares Held After
48,815
% of Holdings
1.8%
Showing 1–50 of 1161 transactions (page 1 of 24)